Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial.

Beigel JH, Aga E, Elie-Turenne MC, Cho J, Tebas P, Clark CL, Metcalf JP, Ozment C, Raviprakash K, Beeler J, Holley HP Jr, Warner S, Chorley C, Lane HC, Hughes MD, Davey RT Jr; IRC005 Study Team.

Lancet Respir Med. 2019 Sep 30. pii: S2213-2600(19)30199-7. doi: 10.1016/S2213-2600(19)30199-7. [Epub ahead of print]

PMID:
31582360
2.

Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial.

Beigel JH, Manosuthi W, Beeler J, Bao Y, Hoppers M, Ruxrungtham K, Beasley RL, Ison M, Avihingsanon A, Losso MH, Langlois N, Hoopes J, Lane HC, Holley HP, Myers CA, Hughes MD, Davey RT.

Clin Infect Dis. 2019 Jul 27. pii: ciz634. doi: 10.1093/cid/ciz634. [Epub ahead of print]

PMID:
31541242
3.

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.

Gamiño-Arroyo AE, Guerrero ML, McCarthy S, Ramírez-Venegas A, Llamosas-Gallardo B, Galindo-Fraga A, Moreno-Espinosa S, Roldán-Aragón Y, Araujo-Meléndez J, Hunsberger S, Ibarra-González V, Martínez-López J, García-Andrade LA, Kapushoc H, Holley HP Jr, Smolskis MC, Ruiz-Palacios GM, Beigel JH; Mexico Emerging Infectious Diseases Clinical Research Network (LaRed).

Clin Infect Dis. 2019 Feb 7. doi: 10.1093/cid/ciz100. [Epub ahead of print]

PMID:
30753384
4.

Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial.

Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, Panuto J, Beasley RL, Perez-Patrigeon S, Suwanpimolkul G, Losso MH, McClure N, Bozzolo DR, Myers C, Holley HP Jr, Hoopes J, Lane HC, Hughes MD, Davey RT; IRC003 Study Team.

Lancet Infect Dis. 2017 Dec;17(12):1255-1265. doi: 10.1016/S1473-3099(17)30476-0. Epub 2017 Sep 22.

5.

Phase II, randomized, multicenter, double-blind, placebo-controlled trial of a polyclonal anti-Staphylococcus aureus capsular polysaccharide immune globulin in treatment of Staphylococcus aureus bacteremia.

Rupp ME, Holley HP Jr, Lutz J, Dicpinigaitis PV, Woods CW, Levine DP, Veney N, Fowler VG Jr.

Antimicrob Agents Chemother. 2007 Dec;51(12):4249-54. Epub 2007 Sep 24.

6.

A blinded, randomized, multicenter study of an intravenous Staphylococcus aureus immune globulin.

Benjamin DK, Schelonka R, White R, Holley HP, Bifano E, Cummings J, Adcock K, Kaufman D, Puppala B, Riedel P, Hall B, White J, Cotton CM; S. aureus prevention investigators.

J Perinatol. 2006 May;26(5):290-5.

PMID:
16598296
7.

Clinafloxacin for the treatment of bacterial endocarditis.

Levine DP, Holley HP, Eiseman I, Willcox P, Tack K.

Clin Infect Dis. 2004 Mar 1;38(5):620-31. Epub 2004 Feb 17.

PMID:
14986244
8.
9.

Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis.

Henry DC, Sydnor A Jr, Settipane GA, Allen J, Burroughs S, Cobb MM, Holley HP Jr.

Clin Ther. 1999 Jul;21(7):1158-70.

PMID:
10463514
10.
11.

Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States.

Doern GV, Brueggemann AB, Blocker M, Dunne M, Holley HP Jr, Kehl KS, Duval J, Kugler K, Putnam S, Rauch A, Pfaller MA.

Clin Infect Dis. 1998 Oct;27(4):757-61.

PMID:
9798029
13.
15.

Comparative Effects of Ceftazidime Two or Three Times Daily in Patients with Skin and Skin Structure Infections.

Gentry LO, Rodriguez-Gomez G, Pien F, Cubeddu L, Holley HP Jr, Buaron K, Giguere G, Collins JJ.

Am J Ther. 1996 Mar;3(3):212-218.

PMID:
11862252
16.

Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG, Holley HP Jr, Marsh RJ, Pfaller MA, McGowan JE Jr, Scully BE, et al.

Clin Infect Dis. 1993 Sep;17(3):466-74.

PMID:
8218691
17.

Successful treatment of cat-scratch disease with ciprofloxacin.

Holley HP Jr.

JAMA. 1991 Mar 27;265(12):1563-5.

PMID:
1999905
18.

Human immunodeficiency virus and the surgeon.

Hebra A, Adams DB, Holley HP Jr.

J S C Med Assoc. 1990 Sep;86(9):479-83. Review.

PMID:
2214685
19.

Cauda equina syndrome secondary to disseminated zygomycosis.

Rozich J, Holley HP Jr, Henderson F, Gardner J, Nelson F.

JAMA. 1988 Dec 23-30;260(24):3638-40.

PMID:
3193592
20.

Cryptosporidiosis in a patient receiving immunosuppressive therapy. Possible activation of latent infection.

Holley HP Jr, Thiers BH.

Dig Dis Sci. 1986 Sep;31(9):1004-7. No abstract available.

PMID:
3525047
21.

Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function.

Lee WM, Holley HP Jr, Stewart J, Galbraith GM.

Am J Med Sci. 1986 Jul;292(1):47-52.

PMID:
3487248
22.

A five-year study of intestinal parasites in Charleston, South Carolina.

Dover C, Holley HP Jr, Jarecki-Black JC, James ER.

J S C Med Assoc. 1986 May;82(5):327-32. No abstract available. Erratum in: J S C Med Assoc 1986 Dec; 82(12):746.

PMID:
3487004
23.

Cryptosporidiosis.

Holley HP Jr.

J S C Med Assoc. 1986 May;82(5):362-3. No abstract available.

PMID:
3458971
24.

Phaeohyphomycosis complicating compound skull fracture.

Biggs PJ, Allen RL, Powers JM, Holley HP Jr.

Surg Neurol. 1986 Apr;25(4):393-6.

PMID:
3952635
25.

Cryptosporidium: a common cause of parasitic diarrhea in otherwise healthy individuals.

Holley HP Jr, Dover C.

J Infect Dis. 1986 Feb;153(2):365-8. No abstract available.

PMID:
3944486
26.

Immunoglobulin class of anti-Candida antibodies in patients with vaginal candidiasis.

Burges G, Holley HP Jr, Virella G.

Diagn Immunol. 1986;4(1):43-6.

PMID:
3514071
27.

Bilateral knee effusions with cefamandole therapy.

Gums JG, Holley HP Jr.

South Med J. 1985 Oct;78(10):1268-9. No abstract available.

PMID:
4049055
28.

Aortic valve endocarditis due to Salmonella enteritidis.

Hanger KH Jr, Goodman R, Usher BW, Holley HP Jr.

South Med J. 1985 Aug;78(8):1023-4.

PMID:
3895451
29.

Infections due to Wangiella dermatitidis in humans: report of the first documented case from the United States and a review of the literature.

Hohl PE, Holley HP Jr, Prevost E, Ajello L, Padhye AA.

Rev Infect Dis. 1983 Sep-Oct;5(5):854-64.

PMID:
6635425
30.

Circulating immune complexes in patients with Candida albicans infections.

Burges G, Holley HP, Virella G.

Clin Exp Immunol. 1983 Jul;53(1):165-74.

31.
32.

Purulent pericarditis complicating coronary artery bypass.

Rotstein C, Holley HP Jr.

South Med J. 1982 Apr;75(4):509-10.

PMID:
6978539
33.

Old problems with new names.

Holley HP Jr, John JF Jr.

JAMA. 1982 Jan 22-29;247(4):463. No abstract available.

PMID:
7054547
34.

Tuberculous peritonitis in patients undergoing chronic home peritoneal dialysis.

Holley HP Jr, Tucker CT, Moffatt TL, Dodds KA, Dodds HM.

Am J Kidney Dis. 1982 Jan;1(4):222-6.

PMID:
6818859
35.

Emphysematous cystitis due to Clostridium perfringens.

West TE, Holley HP Jr, Lauer AD.

JAMA. 1981 Jul 24-31;246(4):363-4. No abstract available.

PMID:
6264173
36.

Immunogenic effect of inactivated hepatitis B vaccine: comparison of 20 microgram and 40 microgram doses.

Krugman S, Holley HP Jr, Davidson M, Simberkoff MS, Matsaniotis N.

J Med Virol. 1981;8(2):119-21.

PMID:
7299377
37.

Prophylaxis against enterococcal endocarditis: comparison of the aminoglycoside component of parenteral antimicrobial regimens.

Murillo J, Standiford HC, Holley HP, Tatem BA, Caplan ES.

Antimicrob Agents Chemother. 1980 Sep;18(3):448-53.

38.

Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines.

Murphy BR, Tierney EL, Barbour BA, Yolken RH, Alling DW, Holley HP Jr, Mayner RE, Chanock RM.

Infect Immun. 1980 Aug;29(2):342-7.

39.

Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.

Murphy BR, Chanock RM, Douglas RG, Betts RF, Waterman DH, Holley HP Jr, Hoover DL, Suwanagool S, Nalin DR, Levine MM.

Arch Virol. 1980;65(2):169-73.

PMID:
7425857
40.

CSF eosinophilia following myelography.

Holley HP Jr, Al-Ibrahim MS.

JAMA. 1979 Nov 30;242(22):2432-3. No abstract available.

PMID:
490858
41.
42.

Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.

Levine MM, Nalin DR, Craig JP, Hoover D, Bergquist EJ, Waterman D, Holley HP, Hornick RB, Pierce NP, Libonati JP.

Trans R Soc Trop Med Hyg. 1979;73(1):3-9.

PMID:
442179
43.

The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera.

Nalin DR, Levine MM, Hornick RB, Bergquist EJ, Hoover D, Holley HP, Waterman D, VanBlerk J, Matheny S, Sotman S, Rennels M.

Trans R Soc Trop Med Hyg. 1979;73(1):10-4.

PMID:
442166
44.

Persistent bacteremia in staphylococcal endocarditis.

Reymann MT, Holley HP Jr, Cobbs CG.

Am J Med. 1978 Nov;65(5):729-37.

PMID:
707532
45.

Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Levine MM, Hughes TP, Young CR, O'Donnell S, Craig JP, Holley HP, Bergquist EJ.

Infect Immun. 1978 Jul;21(1):158-62.

46.

Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers.

Murphy BR, Markoff LJ, Hosier NT, Rusten HM, Chanock RM, Kendal AP, Douglas RG, Betts RF, Cate TR Jr, Couch RB, Levine MM, Waterman DH, Holley HP Jr.

Infect Immun. 1978 Jun;20(3):671-7.

47.

Giardia-induced malabsorption in pancreatitis.

Sheehy TW, Holley HP Jr.

JAMA. 1975 Sep 29;233(13):1373-5.

PMID:
1174210

Supplemental Content

Loading ...
Support Center